Evaluation of Liposome, Heat-Killed Mycobacterium w, and Alum Adjuvants in the Protection Offered by Different Combinations of Recombinant HA, NP proteins, and M2e Against Homologous H5N1 Virus

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Viral immunology

• Publication date

  2016-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1089/vim.2016.0021PMID 27508998
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Intranasal vaccination with a plant-derived H5 HA vaccine protects mice and ferrets against highly pathogenic avian influenza virus challenge

  2015cited by this paper
• Protective Efficacy of a Single Dose of Baculovirus Hemagglutinin-Based Vaccine in Chickens and Ducks Against Homologous and Heterologous H5N1 Virus Infections

  2014cited by this paper
• Avian Influenza (H5N1) Virus of Clade 2.3.2 in Domestic Poultry in India

  2012influential reference
• Evaluation of the immunogenicity of liposome encapsulated HVR1 and NS3 regions of genotype 3 HCV, either singly or in combination

  2012cited by this paper
• Evaluation of recombinant E2 protein-based and whole-virus inactivated candidate vaccines against chikungunya virus.

  2012cited by this paper
• Immunotherapeutic efficacy of Mycobacterium indicus pranii in eliciting anti‐tumor T cell responses: Critical roles of IFNγ

  2012cited by this paper
• Regulation of Antinucleoprotein IgG by Systemic Vaccination and Its Effect on Influenza Virus Clearance

  2011cited by this paper
• Activation of Anti-Tumor Immune Response and Reduction of Regulatory T Cells with Mycobacterium indicus pranii (MIP) Therapy in Tumor Bearing Mice

  2011cited by this paper
• Comparative Efficacy of Hemagglutinin, Nucleoprotein, and Matrix 2 Protein Gene-Based Vaccination against H5N1 Influenza in Mouse and Ferret

  2010cited by this paper
• Heterosubtypic immunity to influenza mediated by liposome adjuvanted H5N1 recombinant protein vaccines.

  2010cited by this paper
• Utility of Pandemic H1N1 2009 Influenza Virus Recombinant Hemagglutinin Protein-Based Enzyme-Linked Immunosorbent Assay for Serosurveillance

  2010cited by this paper
• Evaluation of conserved and variable influenza antigens for immunization against different isolates of H5N1 viruses.

  2009cited by this paper
• Monoclonal antibody recognizing SLLTEVET epitope of M2 protein potently inhibited the replication of influenza A viruses in MDCK cells.

  2009cited by this paper
• Development of candidate combination vaccine for hepatitis E and hepatitis B: a liposome encapsulation approach.

  2009cited by this paper
• Heterosubtypic protection conferred by combined vaccination with M2e peptide and split influenza vaccine.

  2009cited by this paper
• Therapeutic potential of a fully human monoclonal antibody against influenza A virus M2 protein.

  2008cited by this paper
• Effects of adjuvants on the safety and immunogenicity of an avian influenza H5N1 vaccine in adults.

  2008cited by this paper
• Plasmid DNA-based vaccines protect mice and ferrets against lethal challenge with A/Vietnam/1203/04 (H5N1) influenza virus.

  2008cited by this paper
• Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trial.

  2007cited by this paper
• Immunogenicity of candidate hepatitis E virus DNA vaccine expressing complete and truncated ORF2 in mice.

  2007cited by this paper
• Human Transmission But No Pandemic in Indonesia

  2006cited by this paper
• Probable Person-to-Person Transmission of Avian Influenza A (H5N1)

  2006cited by this paper
• Phylogenetic analysis revealed genetic similarity of the H5N1 avian influenza viruses isolated from HPAI outbreaks in chickens in Maharashtra, India with those isolated from swan in Italy and Iran in 2006

  2006cited by this paper
• Safety and immunogenicity of an inactivated adjuvanted whole-virion influenza A (H5N1) vaccine: a phase I randomised controlled trial.

  2006cited by this paper
• Dual expression of the HA protein of H5N2 avian influenza virus in a baculovirus system.

  2006cited by this paper
• Avian influenza. Human transmission but no pandemic in Indonesia.

  2006cited by this paper
• Oseltamivir resistance during treatment of influenza A (H5N1) infection.

  2005cited by this paper
• Probable person-to-person transmission of avian influenza A (H5N1).

  2005cited by this paper
• Protection against multiple influenza A subtypes by vaccination with highly conserved nucleoprotein.

  2005cited by this paper
• Avian flu: Isolation of drug-resistant H5N1 virus

  2005cited by this paper
• Outbreak of avian influenza A(H5N1) virus infection in Hong Kong in 1997.

  2002cited by this paper
• DNA vaccine expressing conserved influenza virus proteins protective against H5N1 challenge infection in mice.

  2002cited by this paper
• Liposomes As Immunological Adjuvants and Vaccine Carriers

  1996cited by this paper
• Evolutionary analysis of the influenza A virus M gene with comparison of the M1 and M2 proteins

  1991cited by this paper

• Mycobacterium w - a promising immunotherapeutic intervention for diseases

  2024cites this paper
• Inter-Clade Protection Offered by Mw-Adjuvanted Recombinant HA, NP Proteins, and M2e Peptide Combination Vaccine in Mice Correlates with Cellular Immune Response

  2017influential citation